Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALML3 | P27482 | 7/20 | 0.55 |
| ▸ | MAOB | P27338 | 10/20 | 0.54 |
| ▸ | MAOA | P21397 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | SDHA | P31040 | 1/20 | 0.54 |
| ▸ | F10 | P00742 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29196827 | 1.00 | CALML3 (0.55) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL28109794 | 0.87 | CALML3 (0.65) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL28109791 | 0.85 | CALML3 (0.64) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL16204405 | 0.85 | CALML3 (0.64) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL5571685 | 0.85 | MAOB (0.76) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL29196813 | 0.85 | CALML3 (0.55) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL29196815 | 0.85 | CALML3 (0.55) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL28110345 | 0.85 | MAOB (0.58) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL28428084 | 0.85 | MAOB (0.58) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL6453422 | 0.85 | CALML3 (0.56) | CALML3MAOBMAOALMNAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116283925-A | Iminophenazine derivative coupling molecule for treating bacterial infection and application thereof | 丹诺医药(苏州)有限公司 | 2023-06-23 | — | — | CN | disclosed |